help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derkx, F. H.
Right arrow Articles by Schalekamp, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derkx, F. H.
Right arrow Articles by Schalekamp, M. A.

Journal of Clinical Endocrinology & Metabolism, Vol 49, 765-769, Copyright © 1979 by Endocrine Society

ARTICLES

Activation of inactive plasma renin by tissue kallikreins

FH Derkx, HL Tan-Tjiong, AJ Man in't Veld, MP Schalekamp and MA Schalekamp

It has been reported that inactive (acid-activable) human renin could be converted into the active form by adding urinary kallikrein to acid- pretreated plasma. Without prior acidification, however, only a small portion of the total amount of inactive renin present in plasma was converted (activated) by kallikrein, probably because native plasma contains protease (kallikrein) inhibitors that are destroyed by acid. We have separated inactive and active renin by DEAE-Sepharose column chromatography of normal human plasma at pH 7.5 and a linearly increasing sodium gradient. Inactive renin isolated in this way could be activated at pH 7.5 by highly purified pancreas and urinary kallikreins. With the semipurified preparation of inactive renin, prior acidification was not required for obtaining virtually complete activation by kallikrein. The kallikreins were effective at concentrations as low as 1 x 10(-8) mol/liter. It is therefore possible that one or more tissue kallikreins act as physiological activators of inactive renin.


This article has been cited by other articles:


Home page
 CirculationHome page
S. Itoh, B. Ding, T. Shishido, N. Lerner-Marmarosh, N. Wang, N. Maekawa, B. C. Berk, Y. Takeishi, C. Yan, B. C. Blaxall, et al.
Role of p90 Ribosomal S6 Kinase-Mediated Prorenin-Converting Enzyme in Ischemic and Diabetic Myocardium
Circulation, April 11, 2006; 113(14): 1787 - 1798.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
N. Picard, M. Van Abel, C. Campone, M. Seiler, M. Bloch-Faure, J. G.J. Hoenderop, J. Loffing, P. Meneton, R. J.M. Bindels, M. Paillard, et al.
Tissue Kallikrein-Deficient Mice Display a Defect in Renal Tubular Calcium Absorption
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3602 - 3610.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
F. A.R. Neves, K. G. Duncan, and J. D. Baxter
Cathepsin B Is a Prorenin Processing Enzyme
Hypertension, March 1, 1996; 27(3): 514 - 517.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society